Know Cancer

or
forgot password

Thromboembolic Complications Related to Asparaginase in Children With ALL Treated According to NOPHO ALL 2008


N/A
1 Year
16 Years
Open (Enrolling)
Both
Thromboembolism, Acute Lymphoblastic Leukemia

Thank you

Trial Information

Thromboembolic Complications Related to Asparaginase in Children With ALL Treated According to NOPHO ALL 2008


Inclusion Criteria:



- Acute lymphoblastic leukaemia,

- Age 1 year to 16 years old,

- Central line,

- Protocol NOPHO ALL 2008.

Exclusion Criteria:

- Refusal of participation,

- Treated according to protocol other than NOPHO ALL 2008.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Clinical evident thrombosis

Outcome Time Frame:

33 weeks

Safety Issue:

No

Principal Investigator

Ellen Ruud, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Oslo University Hospital

Authority:

Norway:National Committee for Medical and Health Research Ethics

Study ID:

ASP NOPHO 2008

NCT ID:

NCT00982514

Start Date:

September 2009

Completion Date:

December 2014

Related Keywords:

  • Thromboembolism
  • Acute Lymphoblastic Leukemia
  • Asparaginase
  • thrombosis
  • ALL
  • central line
  • Leukemia
  • Leukemia, Lymphoid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Thromboembolism

Name

Location